{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:44:16Z","timestamp":1790016256478,"version":"4.0.1"},"publisher-location":"Cham","reference-count":108,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030732332","type":"print"},{"value":"9783030732349","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-73234-9_6","type":"book-chapter","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T20:03:06Z","timestamp":1641240186000},"page":"81-97","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Multifaceted Actions of Curcumin in Obesity"],"prefix":"10.1007","author":[{"given":"Vanessa","family":"Bianconi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pirro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad Hassan","family":"Moallem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bronzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"D\u2019Abbondanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tannaz","family":"Jamialahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"key":"6_CR1","doi-asserted-by":"crossref","unstructured":"Karageorgi, S., Alsmadi, O., & Behbehani, K. (2013). A review of adult obesity prevalence, trends, risk factors, and epidemiologic methods in Kuwait. Journal of Obesity, 2013.","DOI":"10.1155\/2013\/378650"},{"issue":"4","key":"6_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/s-0031-1295684","volume":"24","author":"YM Haidar","year":"2011","unstructured":"Haidar, Y. M., & Cosman, B. C. (2011). Obesity epidemiology. Clinics in Colon and Rectal Surgery, 24(4), 205.","journal-title":"Clinics in Colon and Rectal Surgery"},{"key":"6_CR3","unstructured":"WHO. (2014). Global Status Report on Noncommunicable Diseases, 2014."},{"key":"6_CR4","volume-title":"Prevalence of obesity among adults and youth: United States, 2011\u20132014","author":"CL Ogden","year":"2015","unstructured":"Ogden, C. L., Carroll, M. D., Fryar, C. D., & Flegal, K. M. (2015). Prevalence of obesity among adults and youth: United States, 2011\u20132014. US Department of Health and Human Services, Centers for Disease Control and \u2026."},{"issue":"4","key":"6_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.gtc.2016.07.012","volume":"45","author":"C Arroyo-Johnson","year":"2016","unstructured":"Arroyo-Johnson, C., & Mincey, K. D. (2016). Obesity epidemiology worldwide. Gastroenterology Clinics, 45(4), 571\u2013579.","journal-title":"Gastroenterology Clinics"},{"issue":"4","key":"6_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.pcad.2013.10.016","volume":"56","author":"M Bastien","year":"2014","unstructured":"Bastien, M., Poirier, P., Lemieux, I., & Despr\u00e9s, J.-P. (2014). Overview of epidemiology and contribution of obesity to cardiovascular disease. Progress in Cardiovascular Diseases, 56(4), 369\u2013381.","journal-title":"Progress in Cardiovascular Diseases"},{"issue":"9669","key":"6_CR7","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","volume":"373","author":"Collaboration PS","year":"2009","unstructured":"Collaboration PS. (2009). Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies. The Lancet, 373(9669), 1083\u20131096.","journal-title":"The Lancet"},{"issue":"5","key":"6_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11883-016-0575-4","volume":"18","author":"T Mandviwala","year":"2016","unstructured":"Mandviwala, T., Khalid, U., & Deswal, A. (2016). Obesity and cardiovascular disease: A risk factor or a risk marker? Current Atherosclerosis Reports, 18(5), 21.","journal-title":"Current Atherosclerosis Reports"},{"issue":"6","key":"6_CR9","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.106.171016","volume":"113","author":"P Poirier","year":"2006","unstructured":"Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., et al. (2006). Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation, 113(6), 898\u2013918.","journal-title":"Circulation"},{"issue":"10","key":"6_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.4330\/wjc.v7.i10.603","volume":"7","author":"I Akin","year":"2015","unstructured":"Akin, I., & Nienaber, C. A. (2015). \u201cObesity paradox\u201d in coronary artery disease. World Journal of Cardiology, 7(10), 603.","journal-title":"World Journal of Cardiology"},{"issue":"9491","key":"6_CR11","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KGM Alberti","year":"2005","unstructured":"Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005). The metabolic syndrome\u2014A new worldwide definition. The Lancet, 366(9491), 1059\u20131062.","journal-title":"The Lancet"},{"issue":"1","key":"6_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1472-6823-14-9","volume":"14","author":"JV van Vliet-Ostaptchouk","year":"2014","unstructured":"van Vliet-Ostaptchouk, J. V., Nuotio, M.-L., Slagter, S. N., Doiron, D., Fischer, K., Foco, L., et al. (2014). The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: A collaborative analysis of ten large cohort studies. BMC Endocrine Disorders, 14(1), 9.","journal-title":"BMC Endocrine Disorders"},{"issue":"1","key":"6_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2337\/dc10-0879","volume":"34","author":"A Mozumdar","year":"2011","unstructured":"Mozumdar, A., & Liguori, G. (2011). Persistent increase of prevalence of metabolic syndrome among US adults: NHANES III to NHANES 1999\u20132006. Diabetes Care, 34(1), 216\u2013219.","journal-title":"Diabetes Care"},{"issue":"3","key":"6_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jama.287.3.356","volume":"287","author":"ES Ford","year":"2002","unstructured":"Ford, E. S., Giles, W. H., & Dietz, W. H. (2002). Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA, 287(3), 356\u2013359.","journal-title":"JAMA"},{"key":"6_CR15","doi-asserted-by":"crossref","unstructured":"Hossain P, Kawar B, El Nahas M. (2007) Obesity and diabetes in the developing world\u2013a growing challenge. N Engl J Med. 356(3), 213\u2013215.","DOI":"10.1056\/NEJMp068177"},{"issue":"S2","key":"6_CR16","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1038\/sj.ijo.0802126","volume":"26","author":"J Felber","year":"2002","unstructured":"Felber, J., & Golay, A. (2002). Pathways from obesity to diabetes. International Journal of Obesity, 26(S2), S39.","journal-title":"International Journal of Obesity"},{"key":"6_CR17","doi-asserted-by":"crossref","unstructured":"Han, T. S., & Lean, M. E. (2016). A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovascular Disease, 52048004016633371.","DOI":"10.1177\/2048004016633371"},{"issue":"2","key":"6_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hep.23280","volume":"51","author":"E Fabbrini","year":"2010","unstructured":"Fabbrini, E., Sullivan, S., & Klein, S. (2010). Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology, 51(2), 679\u2013689.","journal-title":"Hepatology"},{"issue":"2","key":"6_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.7326\/0003-4819-132-2-200001180-00004","volume":"132","author":"S Bellentani","year":"2000","unstructured":"Bellentani, S., Saccoccio, G., Masutti, F., Croc\u00e8, L. S., Brandi, G., Sasso, F., et al. (2000). Prevalence of and risk factors for hepatic steatosis in Northern Italy. Annals of Internal Medicine, 132(2), 112\u2013117.","journal-title":"Annals of Internal Medicine"},{"issue":"16","key":"6_CR20","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo, P. (2002). Nonalcoholic fatty liver disease. New England Journal of Medicine, 346(16), 1221\u20131231.","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"6_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.atherosclerosis.2012.07.018","volume":"224","author":"RD Santos","year":"2012","unstructured":"Santos, R. D., & Agewall, S. (2012). Non-alcoholic fatty liver disease and cardiovascular disease. Atherosclerosis, 224(2), 324\u2013325.","journal-title":"Atherosclerosis"},{"issue":"2","key":"6_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1513\/pats.200708-137MG","volume":"5","author":"AR Schwartz","year":"2008","unstructured":"Schwartz, A. R., Patil, S. P., Laffan, A. M., Polotsky, V., Schneider, H., & Smith, P. L. (2008). Obesity and obstructive sleep apnea: Pathogenic mechanisms and therapeutic approaches. Proceedings of the American Thoracic Society, 5(2), 185\u2013192.","journal-title":"Proceedings of the American Thoracic Society"},{"issue":"17","key":"6_CR23","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1056\/NEJM199304293281704","volume":"328","author":"T Young","year":"1993","unstructured":"Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993). The occurrence of sleep-disordered breathing among middle-aged adults. New England Journal of Medicine, 328(17), 1230\u20131235.","journal-title":"New England Journal of Medicine"},{"key":"6_CR24","doi-asserted-by":"crossref","unstructured":"Vats, M. G., Mahboub, B. H., Al Hariri, H., Al Zaabi, A., & Vats, D. (2016). Obesity and Sleep-Related Breathing Disorders in Middle East and UAE. Canadian Respiratory Journal, 2016.","DOI":"10.1155\/2016\/9673054"},{"issue":"12","key":"6_CR25","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1210\/jc.2005-1490","volume":"90","author":"HF Escobar-Morreale","year":"2005","unstructured":"Escobar-Morreale, H. F., Botella-Carretero, J. I., Alvarez-Blasco, F., Sancho, J., & San Mill\u00e1n, J. L. (2005). The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. The Journal of Clinical Endocrinology & Metabolism, 90(12), 6364\u20136369.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"10","key":"6_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1055\/s-0029-1241870","volume":"117","author":"R Percik","year":"2009","unstructured":"Percik, R., & Stumvoll, M. (2009). Obesity and cancer. Experimental and Clinical Endocrinology & Diabetes, 117(10), 563\u2013566.","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"key":"6_CR27","doi-asserted-by":"crossref","unstructured":"De Pergola, G., & Silvestris, F. (2013). Obesity as a major risk factor for cancer. Journal of Obesity, 2013.","DOI":"10.1155\/2013\/291546"},{"issue":"5","key":"6_CR28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/MED.0b013e328355cd6c","volume":"19","author":"EN Pearce","year":"2012","unstructured":"Pearce, E. N. (2012). Thyroid hormone and obesity. Current Opinion in Endocrinology, Diabetes and Obesity, 19(5), 408\u2013413.","journal-title":"Current Opinion in Endocrinology, Diabetes and Obesity"},{"issue":"1","key":"6_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1590\/S1807-59322010000100003","volume":"65","author":"O Tiryakioglu","year":"2010","unstructured":"Tiryakioglu, O., Ugurlu, S., Yalin, S., Yirmibescik, S., Caglar, E., Yetkin, D. O., et al. (2010). Screening for Cushing\u2019s syndrome in obese patients. Clinics, 65(1), 9\u201313.","journal-title":"Clinics"},{"key":"6_CR30","doi-asserted-by":"crossref","unstructured":"Gibson-Smith, D., Bot, M., Paans, N. P., Visser, M., Brouwer, I., & Penninx, B. W. (2016). The role of obesity measures in the development and persistence of major depressive disorder. Journal of Affective Disorders, 198, 222\u2013229.","DOI":"10.1016\/j.jad.2016.03.032"},{"issue":"2","key":"6_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/sj.ijo.0803715","volume":"32","author":"A Anandacoomarasamy","year":"2008","unstructured":"Anandacoomarasamy, A., Caterson, I., Sambrook, P., Fransen, M., & March, L. (2008). The impact of obesity on the musculoskeletal system. International Journal of Obesity, 32(2), 211.","journal-title":"International Journal of Obesity"},{"issue":"5","key":"6_CR32","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/sj.ijo.0801585","volume":"25","author":"D Coggon","year":"2001","unstructured":"Coggon, D., Reading, I., Croft, P., McLaren, M., Barrett, D., & Cooper, C. (2001). Knee osteoarthritis and obesity. International Journal of Obesity, 25(5), 622.","journal-title":"International Journal of Obesity"},{"issue":"2","key":"6_CR33","first-page":"185","volume":"138","author":"LK King","year":"2013","unstructured":"King, L. K., March, L., & Anandacoomarasamy, A. (2013). Obesity & osteoarthritis. The Indian Journal of Medical Research, 138(2), 185.","journal-title":"The Indian Journal of Medical Research"},{"issue":"2","key":"6_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nri2922","volume":"11","author":"D Mathis","year":"2011","unstructured":"Mathis, D., & Shoelson, S. E. (2011). Immunometabolism: An emerging frontier. Nature Reviews Immunology, 11(2), 81.","journal-title":"Nature Reviews Immunology"},{"issue":"1","key":"6_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cmet.2011.10.011","volume":"15","author":"R Stienstra","year":"2012","unstructured":"Stienstra, R., Tack, C. J., Kanneganti, T.-D., Joosten, L. A., & Netea, M. G. (2012). The inflammasome puts obesity in the danger zone. Cell Metabolism, 15(1), 10\u201318.","journal-title":"Cell Metabolism"},{"issue":"3","key":"6_CR36","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/MOL.0b013e3283393867","volume":"21","author":"EK Anderson","year":"2010","unstructured":"Anderson, E. K., Gutierrez, D. A., & Hasty, A. H. (2010). Adipose tissue recruitment of leukocytes. Current Opinion in Lipidology, 21(3), 172.","journal-title":"Current Opinion in Lipidology"},{"issue":"3","key":"6_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017154","volume":"6","author":"K Meijer","year":"2011","unstructured":"Meijer, K., de Vries, M., Al-Lahham, S., Bruinenberg, M., Weening, D., Dijkstra, M., et al. (2011). Human primary adipocytes exhibit immune cell function: Adipocytes prime inflammation independent of macrophages. PLoS One, 6(3), e17154.","journal-title":"PLoS One"},{"key":"6_CR38","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Hern\u00e1ndez, H., Simental-Mend\u00eda, L. E., Rodr\u00edguez-Ram\u00edrez, G., & Reyes-Romero, M. A. (2013). Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. International Journal of Endocrinology, 2013.","DOI":"10.1155\/2013\/678159"},{"issue":"5","key":"6_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2217\/17460875.3.5.545","volume":"3","author":"B Surmi","year":"2008","unstructured":"Surmi, B., & Hasty, A. (2008). Macrophage infiltration into adipose tissue: Initiation, propagation and remodeling. Future Lipidology, 3(5), 545\u2013556.","journal-title":"Future Lipidology"},{"issue":"2","key":"6_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/obr.12242","volume":"16","author":"Y Bai","year":"2015","unstructured":"Bai, Y., & Sun, Q. (2015). Macrophage recruitment in obese adipose tissue. Obesity Reviews, 16(2), 127\u2013136.","journal-title":"Obesity Reviews"},{"key":"6_CR41","doi-asserted-by":"crossref","unstructured":"Ray, I., Mahata, S. K., & De, R. K. (2016). Obesity: An immunometabolic perspective. Frontiers in Endocrinology, 7157.","DOI":"10.3389\/fendo.2016.00157"},{"issue":"12","key":"6_CR42","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1042\/CS20150431","volume":"129","author":"JB McPhee","year":"2015","unstructured":"McPhee, J. B., & Schertzer, J. D. (2015). Immunometabolism of obesity and diabetes: Microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation. Clinical Science, 129(12), 1083\u20131096.","journal-title":"Clinical Science"},{"issue":"4","key":"6_CR43","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/nu5041218","volume":"5","author":"B Klop","year":"2013","unstructured":"Klop, B., Elte, J. W. F., & Cabezas, M. C. (2013). Dyslipidemia in obesity: Mechanisms and potential targets. Nutrients, 5(4), 1218\u20131240.","journal-title":"Nutrients"},{"key":"6_CR44","unstructured":"Feingold KR. Obesity and Dyslipidemia. [Updated 2020 Nov 2]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.\u00a0Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK305895\/\u00a0"},{"issue":"2","key":"6_CR45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MED.0b013e3283514e13","volume":"19","author":"OT Hardy","year":"2012","unstructured":"Hardy, O. T., Czech, M. P., & Corvera, S. (2012). What causes the insulin resistance underlying obesity? Current Opinion in Endocrinology, Diabetes, and Obesity, 19(2), 81.","journal-title":"Current Opinion in Endocrinology, Diabetes, and Obesity"},{"issue":"6","key":"6_CR46","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1590\/0004-2730000003223","volume":"58","author":"AVB Castro","year":"2014","unstructured":"Castro, A. V. B., Kolka, C. M., Kim, S. P., & Bergman, R. N. (2014). Obesity, insulin resistance and comorbidities? Mechanisms of association. Arquivos Brasileiros de Endocrinologia & Metabologia, 58(6), 600\u2013609.","journal-title":"Arquivos Brasileiros de Endocrinologia & Metabologia"},{"issue":"10","key":"6_CR47","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.metabol.2007.06.009","volume":"56","author":"OD Carlson","year":"2007","unstructured":"Carlson, O. D., David, J. D., Schrieder, J. M., Muller, D. C., Jang, H.-J., Kim, B.-J., et al. (2007). Contribution of nonesterified fatty acids to insulin resistance in the elderly with normal fasting but diabetic 2-hour postchallenge plasma glucose levels: The Baltimore Longitudinal Study of Aging. Metabolism, 56(10), 1444\u20131451.","journal-title":"Metabolism"},{"issue":"10","key":"6_CR48","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.2337\/db11-0425","volume":"60","author":"F Karpe","year":"2011","unstructured":"Karpe, F., Dickmann, J. R., & Frayn, K. N. (2011). Fatty acids, obesity, and insulin resistance: Time for a reevaluation. Diabetes, 60(10), 2441\u20132449.","journal-title":"Diabetes"},{"issue":"2","key":"6_CR49","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/jcp.25778","volume":"233","author":"E Abdollahi","year":"2018","unstructured":"Abdollahi, E., Momtazi, A. A., Johnston, T. P., & Sahebkar, A. (2018). Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades? Journal of Cellular Physiology, 233(2), 830\u2013848.","journal-title":"Journal of Cellular Physiology"},{"issue":"3\u20134","key":"6_CR50","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.phymed.2009.05.020","volume":"17","author":"M Iranshahi","year":"2010","unstructured":"Iranshahi, M., Sahebkar, A., Hosseini, S. T., Takasaki, M., Konoshima, T., & Tokuda, H. (2010). Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine, 17(3\u20134), 269\u2013273.","journal-title":"Phytomedicine"},{"issue":"1","key":"6_CR51","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/10408398.2017.1358139","volume":"59","author":"H Mollazadeh","year":"2019","unstructured":"Mollazadeh, H., Cicero, A. F. G., Blesso, C. N., Pirro, M., Majeed, M., & Sahebkar, A. (2019). Immune modulation by curcumin: The role of interleukin-10. Critical Reviews in Food Science and Nutrition, 59(1), 89\u2013101.","journal-title":"Critical Reviews in Food Science and Nutrition"},{"issue":"4","key":"6_CR52","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40291-016-0202-7","volume":"20","author":"AA Momtazi","year":"2016","unstructured":"Momtazi, A. A., Derosa, G., Maffioli, P., Banach, M., & Sahebkar, A. (2016). Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases. Molecular Diagnosis and Therapy, 20(4), 335\u2013345.","journal-title":"Molecular Diagnosis and Therapy"},{"key":"6_CR53","doi-asserted-by":"crossref","unstructured":"Panahi, Y., Ahmadi, Y., Teymouri, M., Johnston, T.P., Sahebkar, A. (2018). Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms. Journal of Cellular Physiology, 233(1), 141\u2013152.\u00a0","DOI":"10.1002\/jcp.25756"},{"key":"6_CR54","doi-asserted-by":"crossref","unstructured":"Ghandadi, M., Sahebkar, A. (2017) Curcumin: An effective inhibitor of interleukin-6. Current Pharmaceutical Design, 23(6), 921\u2013931.","DOI":"10.2174\/1381612822666161006151605"},{"key":"6_CR55","doi-asserted-by":"crossref","unstructured":"Panahi, Y., Khalili, N., Sahebi, E., Namazi, S., Simental-Mend\u00eda, L.E., Majeed, M., Sahebkar, A. (2018) Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes Mellitus: a randomized double-blind placebo-controlled trial. Drug Research, 68(7), 403\u2013409.","DOI":"10.1055\/s-0044-101752"},{"issue":"3","key":"6_CR56","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/biof.1344","volume":"43","author":"M Teymouri","year":"2017","unstructured":"Teymouri, M., Pirro, M., Johnston, T. P., & Sahebkar, A. (2017). Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features. BioFactors, 43(3), 331\u2013346.","journal-title":"BioFactors"},{"key":"6_CR57","doi-asserted-by":"crossref","unstructured":"Johnston, T. P., Korolenko, T. A., Pirro, M., & Sahebkar, A. (2017). Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management. Pharmacological Research, 120, 219\u2013225.","DOI":"10.1016\/j.phrs.2017.04.008"},{"issue":"1","key":"6_CR58","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/biof.1074","volume":"39","author":"PG Bradford","year":"2013","unstructured":"Bradford, P. G. (2013). Curcumin and obesity. BioFactors, 39(1), 78\u201387.","journal-title":"BioFactors"},{"key":"6_CR59","doi-asserted-by":"crossref","unstructured":"Aggarwal, B. B. (2010). Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annual Review of Nutrition, 30, 173\u2013199.","DOI":"10.1146\/annurev.nutr.012809.104755"},{"issue":"2","key":"6_CR60","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2217\/fon.11.145","volume":"8","author":"A Shehzad","year":"2012","unstructured":"Shehzad, A., Khan, S., & Sup Lee, Y. (2012). Curcumin molecular targets in obesity and obesity-related cancers. Future Oncology, 8(2), 179\u2013190.","journal-title":"Future Oncology"},{"issue":"2","key":"6_CR61","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bfopcu.2014.05.001","volume":"52","author":"GA Mohamed","year":"2014","unstructured":"Mohamed, G. A., Ibrahim, S. R., Elkhayat, E. S., & El Dine, R. S. (2014). Natural anti-obesity agents. Bulletin of Faculty of Pharmacy, Cairo University, 52(2), 269\u2013284.","journal-title":"Bulletin of Faculty of Pharmacy, Cairo University"},{"issue":"3","key":"6_CR62","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00394-011-0188-1","volume":"50","author":"A Shehzad","year":"2011","unstructured":"Shehzad, A., Ha, T., Subhan, F., & Lee, Y. S. (2011). New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. European Journal of Nutrition, 50(3), 151\u2013161.","journal-title":"European Journal of Nutrition"},{"issue":"2","key":"6_CR63","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nm1185","volume":"11","author":"MC Arkan","year":"2005","unstructured":"Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., et al. (2005). IKK-\u03b2 links inflammation to obesity-induced insulin resistance. Nature Medicine, 11(2), 191.","journal-title":"Nature Medicine"},{"issue":"8","key":"6_CR64","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/bph.12131","volume":"169","author":"BB Aggarwal","year":"2013","unstructured":"Aggarwal, B. B., Gupta, S. C., & Sung, B. (2013). Curcumin: An orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. British Journal of Pharmacology, 169(8), 1672\u20131692.","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"6_CR65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/biof.1041","volume":"39","author":"S Shishodia","year":"2013","unstructured":"Shishodia, S. (2013). Molecular mechanisms of curcumin action: Gene expression. BioFactors, 39(1), 37\u201355.","journal-title":"BioFactors"},{"issue":"6","key":"6_CR66","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.4049\/jimmunol.163.6.3474","volume":"163","author":"C Jobin","year":"1999","unstructured":"Jobin, C., Bradham, C. A., Russo, M. P., Juma, B., Narula, A. S., Brenner, D. A., et al. (1999). Curcumin blocks cytokine-mediated NF-\u03baB activation and proinflammatory gene expression by inhibiting inhibitory factor I-\u03baB kinase activity. The Journal of Immunology, 163(6), 3474\u20133483.","journal-title":"The Journal of Immunology"},{"issue":"1","key":"6_CR67","doi-asserted-by":"publisher","first-page":"e28784","DOI":"10.1371\/journal.pone.0028784","volume":"7","author":"W Shao","year":"2012","unstructured":"Shao, W., Yu, Z., Chiang, Y., Yang, Y., Chai, T., Foltz, W., et al. (2012). Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS One, 7(1), e28784.","journal-title":"PLoS One"},{"issue":"5","key":"6_CR68","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1194\/jlr.M600471-JLR200","volume":"48","author":"J Laurencikiene","year":"2007","unstructured":"Laurencikiene, J., Van Harmelen, V., Nordstr\u00f6m, E. A., Dicker, A., Blomqvist, L., N\u00e4slund, E., et al. (2007). NF-\u03baB is important for TNF-\u03b1-induced lipolysis in human adipocytes. Journal of Lipid Research, 48(5), 1069\u20131077.","journal-title":"Journal of Lipid Research"},{"issue":"1","key":"6_CR69","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1743-7075-5-17","volume":"5","author":"AM Gonzales","year":"2008","unstructured":"Gonzales, A. M., & Orlando, R. A. (2008). Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutrition & metabolism, 5(1), 17.","journal-title":"Nutrition & metabolism"},{"issue":"1","key":"6_CR70","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1074\/jbc.M110.139139","volume":"286","author":"S Ghoshal","year":"2011","unstructured":"Ghoshal, S., Trivedi, D. B., Graf, G. A., & Loftin, C. D. (2011). Cyclooxygenase-2 deficiency attenuates adipose tissue differentiation and inflammation in mice. Journal of Biological Chemistry, 286(1), 889\u2013898.","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"6_CR71","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/oby.2008.674","volume":"17","author":"PS Hsieh","year":"2009","unstructured":"Hsieh, P. S., Jin, J. S., Chiang, C. F., Chan, P. C., Chen, C. H., & Shih, K. C. (2009). COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity, 17(6), 1150\u20131157.","journal-title":"Obesity"},{"issue":"5091","key":"6_CR72","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993). Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science, 259(5091), 87\u201391.","journal-title":"Science"},{"issue":"1","key":"6_CR73","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1210\/endo.134.1.8275942","volume":"134","author":"C Hofmann","year":"1994","unstructured":"Hofmann, C., Lorenz, K., Braithwaite, S., Colca, J., Palazuk, B., Hotamisligil, G., et al. (1994). Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology, 134(1), 264\u2013270.","journal-title":"Endocrinology"},{"issue":"5","key":"6_CR74","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI117899","volume":"95","author":"PA Kern","year":"1995","unstructured":"Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., & Simsolo, R. B. (1995). The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. The Journal of Clinical Investigation, 95(5), 2111\u20132119.","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"6_CR75","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1172\/JCI117936","volume":"95","author":"GS Hotamisligil","year":"1995","unstructured":"Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995). Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. The Journal of Clinical Investigation, 95(5), 2409\u20132415.","journal-title":"The Journal of Clinical Investigation"},{"issue":"10","key":"6_CR76","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.lfs.2006.11.030","volume":"80","author":"H-M Woo","year":"2007","unstructured":"Woo, H.-M., Kang, J.-H., Kawada, T., Yoo, H., Sung, M.-K., & Yu, R. (2007). Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes. Life Sciences, 80(10), 926\u2013931.","journal-title":"Life Sciences"},{"issue":"11","key":"6_CR77","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.2337\/db11-0275","volume":"60","author":"SK Yekollu","year":"2011","unstructured":"Yekollu, S. K., Thomas, R., & O\u2019sullivan, B. (2011). Targeting curcusomes to inflammatory dendritic cells inhibits NF-\u03baB and improves insulin resistance in obese mice. Diabetes, 60(11), 2928\u20132938.","journal-title":"Diabetes"},{"issue":"3","key":"6_CR78","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3109\/07357907.2010.550592","volume":"29","author":"Z-Y He","year":"2011","unstructured":"He, Z.-Y., Shi, C.-B., Wen, H., Li, F.-L., Wang, B.-L., & Wang, J. (2011). Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Investigation, 29(3), 208\u2013213.","journal-title":"Cancer Investigation"},{"issue":"4","key":"6_CR79","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2165\/00126839-200809040-00004","volume":"9","author":"P Usharani","year":"2008","unstructured":"Usharani, P., Mateen, A., Naidu, M., Raju, Y., & Chandra, N. (2008). Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus. Drugs in R & D, 9(4), 243\u2013250.","journal-title":"Drugs in R & D"},{"issue":"6","key":"6_CR80","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1210\/jc.2003-031826","volume":"89","author":"AM Xydakis","year":"2004","unstructured":"Xydakis, A. M., Case, C. C., Jones, P. H., Hoogeveen, R. C., Liu, M.-Y., EOb, S., et al. (2004). Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. The Journal of Clinical Endocrinology & Metabolism, 89(6), 2697\u20132703.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"6_CR81","first-page":"10","volume":"16","author":"H-S Lee","year":"2007","unstructured":"Lee, H.-S., Lee, M.-S., & Joung, H.-J. (2007). Adiponectin represents an independent risk factor for hypertension in middle aged Korean women. Asia Pacific Journal of Clinical Nutrition, 16(1), 10\u201315.","journal-title":"Asia Pacific Journal of Clinical Nutrition"},{"issue":"10","key":"6_CR82","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.nut.2016.03.018","volume":"32","author":"Y Panahi","year":"2016","unstructured":"Panahi, Y., Hosseini, M. S., Khalili, N., Naimi, E., Soflaei, S. S., Majeed, M., et al. (2016). Effects of supplementation with curcumin on serum adipokine concentrations: A randomized controlled trial. Nutrition, 32(10), 1116\u20131122.","journal-title":"Nutrition"},{"issue":"7","key":"6_CR83","first-page":"711","volume":"6","author":"X Qu","year":"2008","unstructured":"Qu, X., Zhao, S., Xu, J., & Dong, L. (2008). Effects of curcumin on secretion of adiponectin and interleukin-6 in human adipose tissues: an in vitro study. Zhong xi yi jie he xue bao = Journal of Chinese Integrative Medicine, 6(7), 711\u2013715.","journal-title":"Zhong xi yi jie he xue bao = Journal of Chinese Integrative Medicine"},{"issue":"5","key":"6_CR84","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4162\/nrp.2016.10.5.487","volume":"10","author":"W-Y Song","year":"2016","unstructured":"Song, W.-Y., & Choi, J.-H. (2016). Korean Curcuma longa L. induces lipolysis and regulates leptin in adipocyte cells and rats. Nutrition Research and Practice, 10(5), 487\u2013493.","journal-title":"Nutrition Research and Practice"},{"key":"6_CR85","doi-asserted-by":"crossref","unstructured":"Karimian, M. S., Pirro, M., Majeed, M., & Sahebkar, A. (2017). Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine & Growth Factor Reviews, 33, 55\u201363.","DOI":"10.1016\/j.cytogfr.2016.10.001"},{"issue":"12","key":"6_CR86","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1753-4887.2010.00341.x","volume":"68","author":"L Alappat","year":"2010","unstructured":"Alappat, L., & Awad, A. B. (2010). Curcumin and obesity: Evidence and mechanisms. Nutrition Reviews, 68(12), 729\u2013738.","journal-title":"Nutrition Reviews"},{"issue":"5","key":"6_CR87","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/oby.2008.601","volume":"17","author":"LA Videla","year":"2009","unstructured":"Videla, L. A., Tapia, G., Rodrigo, R., Pettinelli, P., Haim, D., Santiba\u00f1ez, C., et al. (2009). Liver NF-\u03baB and AP-1 DNA binding in obese patients. Obesity, 17(5), 973\u2013979.","journal-title":"Obesity"},{"issue":"4","key":"6_CR88","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1055\/s-0038-1656049","volume":"77","author":"A Bierhaus","year":"1997","unstructured":"Bierhaus, A., Zhang, Y., Quehenberger, P., Luther, T., Haase, M., M\u00fcller, M., et al. (1997). The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thrombosis and Haemostasis, 77(4), 772\u2013782.","journal-title":"Thrombosis and Haemostasis"},{"issue":"8","key":"6_CR89","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1093\/jn\/131.8.2090","volume":"131","author":"K Okada","year":"2001","unstructured":"Okada, K., Wangpoengtrakul, C., Tanaka, T., Toyokuni, S., Uchida, K., & Osawa, T. (2001). Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. The Journal of Nutrition, 131(8), 2090\u20132095.","journal-title":"The Journal of Nutrition"},{"issue":"11","key":"6_CR90","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1093\/jn\/131.11.2932","volume":"131","author":"A Asai","year":"2001","unstructured":"Asai, A., & Miyazawa, T. (2001). Dietary curcuminoids prevent high-fat diet\u2013induced lipid accumulation in rat liver and epididymal adipose tissue. The Journal of Nutrition, 131(11), 2932\u20132935.","journal-title":"The Journal of Nutrition"},{"issue":"11","key":"6_CR91","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.metabol.2008.06.014","volume":"57","author":"E-M Jang","year":"2008","unstructured":"Jang, E.-M., Choi, M.-S., Jung, U. J., Kim, M.-J., Kim, H.-J., Jeon, S.-M., et al. (2008). Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat\u2013fed hamsters. Metabolism, 57(11), 1576\u20131583.","journal-title":"Metabolism"},{"issue":"5","key":"6_CR92","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.fct.2011.02.004","volume":"49","author":"MA El-Moselhy","year":"2011","unstructured":"El-Moselhy, M. A., Taye, A., Sharkawi, S. S., El-Sisi, S. F., & Ahmed, A. F. (2011). The antihyperglycemic effect of curcumin in high fat diet fed rats. Role of TNF-\u03b1 and free fatty acids. Food and Chemical Toxicology, 49(5), 1129\u20131140.","journal-title":"Food and Chemical Toxicology"},{"issue":"2","key":"6_CR93","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jnutbio.2006.03.007","volume":"18","author":"D Peschel","year":"2007","unstructured":"Peschel, D., Koerting, R., & Nass, N. (2007). Curcumin induces changes in expression of genes involved in cholesterol homeostasis. The Journal of Nutritional Biochemistry, 18(2), 113\u2013119.","journal-title":"The Journal of Nutritional Biochemistry"},{"issue":"3","key":"6_CR94","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ptr.4715","volume":"27","author":"A Mohammadi","year":"2013","unstructured":"Mohammadi, A., Sahebkar, A., Iranshahi, M., Amini, M., Khojasteh, R., Ghayour-Mobarhan, M., et al. (2013). Effects of supplementation with curcuminoids on dyslipidemia in obese patients: A randomized crossover trial. Phytotherapy Research, 27(3), 374\u2013379.","journal-title":"Phytotherapy Research"},{"issue":"6","key":"6_CR95","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/biof.1302","volume":"42","author":"AS Jim\u00e9nez-Osorio","year":"2016","unstructured":"Jim\u00e9nez-Osorio, A. S., Monroy, A., & Alavez, S. (2016). Curcumin and insulin resistance\u2014Molecular targets and clinical evidences. BioFactors, 42(6), 561\u2013580.","journal-title":"BioFactors"},{"issue":"6","key":"6_CR96","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1074\/jbc.275.6.4283","volume":"275","author":"BJ Goldstein","year":"2000","unstructured":"Goldstein, B. J., Bittner-Kowalczyk, A., White, M. F., & Harbeck, M. (2000). Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. Journal of Biological Chemistry, 275(6), 4283\u20134289.","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"6_CR97","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/hep.23524","volume":"51","author":"JM Li","year":"2010","unstructured":"Li, J. M., Li, Y. C., Kong, L. D., & Hu, Q. H. (2010). Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats. Hepatology, 51(5), 1555\u20131566.","journal-title":"Hepatology"},{"issue":"7","key":"6_CR98","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.numecd.2009.11.009","volume":"21","author":"L-X Na","year":"2011","unstructured":"Na, L.-X., Zhang, Y.-L., Li, Y., Liu, L.-Y., Li, R., Kong, T., et al. (2011). Curcumin improves insulin resistance in skeletal muscle of rats. Nutrition, Metabolism and Cardiovascular Diseases, 21(7), 526\u2013533.","journal-title":"Nutrition, Metabolism and Cardiovascular Diseases"},{"issue":"1","key":"6_CR99","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0895-3988(09)60019-2","volume":"22","author":"W Shao-Ling","year":"2009","unstructured":"Shao-Ling, W., Ying, L., Ying, W., Yan-Feng, C., Li-Xin, N., Song-Tao, L., et al. (2009). Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway. Biomedical and Environmental Sciences, 22(1), 32\u201339.","journal-title":"Biomedical and Environmental Sciences"},{"issue":"7","key":"6_CR100","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1210\/en.2008-0262","volume":"149","author":"SP Weisberg","year":"2008","unstructured":"Weisberg, S. P., Leibel, R., & Tortoriello, D. V. (2008). Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology, 149(7), 3549\u20133558.","journal-title":"Endocrinology"},{"key":"6_CR101","doi-asserted-by":"crossref","unstructured":"Chuengsamarn, S., Rattanamongkolgul, S., Luechapudiporn, R., Phisalaphong, C., & Jirawatnotai, S. (2012). Curcumin extract for prevention of type 2 diabetes. Diabetes Care DC_120116.","DOI":"10.2337\/dc12-0116"},{"issue":"9","key":"6_CR102","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/mnfr.201200131","volume":"57","author":"LX Na","year":"2013","unstructured":"Na, L. X., Li, Y., Pan, H. Z., Zhou, X. L., Sun, D. J., Meng, M., et al. (2013). Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: A double-blind, placebo-controlled trial. Molecular Nutrition & Food Research, 57(9), 1569\u20131577.","journal-title":"Molecular Nutrition & Food Research"},{"issue":"1","key":"6_CR103","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tem.2008.09.002","volume":"20","author":"C Christodoulides","year":"2009","unstructured":"Christodoulides, C., Lagathu, C., Sethi, J. K., & Vidal-Puig, A. (2009). Adipogenesis and WNT signalling. Trends in Endocrinology & Metabolism, 20(1), 16\u201324.","journal-title":"Trends in Endocrinology & Metabolism"},{"issue":"4","key":"6_CR104","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2337\/db14-1164","volume":"64","author":"JJ Fuster","year":"2015","unstructured":"Fuster, J. J., Zuriaga, M. A., Ngo, D. T.-M., Farb, M. G., Aprahamian, T., Yamaguchi, T. P., et al. (2015). Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion. Diabetes, 64(4), 1235\u20131248.","journal-title":"Diabetes"},{"issue":"6","key":"6_CR105","doi-asserted-by":"publisher","first-page":"C1510","DOI":"10.1152\/ajpcell.00369.2009","volume":"298","author":"J Ahn","year":"2010","unstructured":"Ahn, J., Lee, H., Kim, S., & Ha, T. (2010). Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt\/\u03b2-catenin signaling. American Journal of Physiology-Cell Physiology, 298(6), C1510\u2013C1516.","journal-title":"American Journal of Physiology-Cell Physiology"},{"key":"6_CR106","doi-asserted-by":"crossref","unstructured":"Lone, J., Choi, J. H., Kim, S. W., & Yun, J. W. (2016). Curcumin induces brown fat-like phenotype in 3T3-L1 and primary white adipocytes. The Journal of Nutritional Biochemistry, 27, 193\u2013202.","DOI":"10.1016\/j.jnutbio.2015.09.006"},{"issue":"5","key":"6_CR107","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3945\/jn.108.100966","volume":"139","author":"A Ejaz","year":"2009","unstructured":"Ejaz, A., Wu, D., Kwan, P., & Meydani, M. (2009). Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57\/BL mice. The Journal of Nutrition, 139(5), 919\u2013925.","journal-title":"The Journal of Nutrition"},{"issue":"46","key":"6_CR108","doi-asserted-by":"publisher","first-page":"75659","DOI":"10.18632\/oncotarget.12318","volume":"7","author":"J Zhang","year":"2016","unstructured":"Zhang, J., Wang, J., Xu, J., Lu, Y., Jiang, J., Wang, L., et al. (2016). Curcumin targets the TFEB-lysosome pathway for induction of autophagy. Oncotarget, 7(46), 75659.","journal-title":"Oncotarget"}],"container-title":["Advances in Experimental Medicine and Biology","Natural Products and Human Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-73234-9_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T14:24:32Z","timestamp":1676125472000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-73234-9_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030732332","9783030732349"],"references-count":108,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-73234-9_6","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"3 January 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}